Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy
Source abstract
Abstract
Abstract Nanomedicines have the potential to provide advanced therapeutic strategies in combating tumors. Polymer‐prodrug‐based nanomedicines are particularly attractive in cancer therapies owing to the maximum drug loading, prolonged blood circulation, and reduced premature leakage and side effects in comparison with conventional nanomaterials. However, the difficulty in precisely tuning the composition and drug loading of polymer–drug conjugates leads to batch‐to‐batch variations of the prodrugs, thus significantly restricting their clinical translation. Polyprodrug nanomedicines inherit the numerous intrinsic advantages of polymer–drug conjugates and exhibit well‐controlled composition and drug loading via direct polymerization of therapeutic monomers, representing a promising nanomedicine for clinical tumor therapies. In this review, recent advances in the development of polyprodrug nanomedicines are summarized for tumor elimination. Various types of polyprodrug nanomedicines and the corresponding properties are first summarized. The unique advantages of polyprodrug nanomedicines and their key roles in various tumor therapies are further highlighted. Finally, current challenges and the perspectives on future research of polyprodrug nanomedicines are discussed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Life Science and Technology Harbin Institute of Technology Harbin Heilongjiang 150080 P. R. China
State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Science University of Macau Avenida da Universidade Taipa Macau 999078 P. R. China
MoE Frontiers Science Center for Precision Oncology University of Macau Macau P. R. China
Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology Department of Chemistry Tsinghua University Beijing 100084 P. R. China
State Key Laboratory of Molecular Engineering of Polymers Department of Macromolecular Science Fudan University Shanghai 200438 P. R. China
Departments of Diagnostic Radiology Surgery, Chemical and Biomolecular Engineering and Biomedical Engineering Yong Loo Lin School of Medicine and Faculty of Engineering National University of Singapore Singapore 119074 Singapore
Clinical Imaging Research Centre Centre for Translational Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117599 Singapore
Nanomedicine Translational Research Program NUS Center for Nanomedicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117597 Singapore
Funding
Science and Technology Development Fund · Universidade de Macau · National Natural Science Foundation of China
References (100+)
Show source-provided references
1. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
2. 10.1056/NEJMra091227310.1056/NEJMra0912273 ↗
3. 10.1021/ar200019c10.1021/ar200019c ↗
4. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
5. 10.1016/j.jconrel.2014.12.03010.1016/j.jconrel.2014.12.030 ↗
6. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
7. 10.1016/j.jconrel.2012.04.03810.1016/j.jconrel.2012.04.038 ↗
8. 10.1016/j.addr.2010.10.00810.1016/j.addr.2010.10.008 ↗
9. 10.1002/btm2.1014310.1002/btm2.10143 ↗
10. 10.1002/adma.20170532810.1002/adma.201705328 ↗
11. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
12. 10.1016/j.nantod.2019.02.00510.1016/j.nantod.2019.02.005 ↗
13. 10.1021/acs.chemrev.5b0011610.1021/acs.chemrev.5b00116 ↗
14. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
15. 10.1002/adma.20160662810.1002/adma.201606628 ↗
16. 10.1021/acsnano.6b0824410.1021/acsnano.6b08244 ↗
17. 10.1002/adma.20170430710.1002/adma.201704307 ↗
18. 10.1038/nrc195810.1038/nrc1958 ↗
19. 10.1002/anie.20050211310.1002/anie.200502113 ↗
20. 10.1016/j.progpolymsci.2005.09.00410.1016/j.progpolymsci.2005.09.004 ↗
21. 10.1016/j.tibtech.2005.11.00610.1016/j.tibtech.2005.11.006 ↗
22. 10.1002/adma.20200001310.1002/adma.202000013 ↗
23. 10.1002/anie.20200873210.1002/anie.202008732 ↗
24. 10.1002/anie.20161178310.1002/anie.201611783 ↗
25. 10.1002/adma.20190721010.1002/adma.201907210 ↗
26. 10.1016/j.cocis.2017.08.00210.1016/j.cocis.2017.08.002 ↗
27. 10.1016/j.addr.2009.05.00610.1016/j.addr.2009.05.006 ↗
28. 10.1016/j.ebiom.2020.10282110.1016/j.ebiom.2020.102821 ↗
29. 10.1002/wnan.158510.1002/wnan.1585 ↗
30. 10.1021/acsami.9b1021110.1021/acsami.9b10211 ↗
31. 10.1021/acs.bioconjchem.8b0023810.1021/acs.bioconjchem.8b00238 ↗
32. 10.1039/D1PY00128K10.1039/D1PY00128K ↗
33. 10.1021/acs.chemmater.8b0114910.1021/acs.chemmater.8b01149 ↗
34. Li J. G. · Mol. Pharmaceutics · 2020 · 17 · 710
35. 10.1039/C9CC06567A10.1039/C9CC06567A ↗
36. 10.1002/adfm.20180864610.1002/adfm.201808646 ↗
37. 10.1002/adma.20160370210.1002/adma.201603702 ↗
38. 10.1002/adma.20200476610.1002/adma.202004766 ↗
39. 10.1016/j.biomaterials.2020.12021010.1016/j.biomaterials.2020.120210 ↗
40. 10.1021/acs.nanolett.7b0353110.1021/acs.nanolett.7b03531 ↗
41. 10.1021/ar900035f10.1021/ar900035f ↗
42. 10.1016/j.biomaterials.2011.05.04910.1016/j.biomaterials.2011.05.049 ↗
43. 10.1039/C4CS00229F10.1039/C4CS00229F ↗
44. 10.1021/ar900158p10.1021/ar900158p ↗
45. 10.1039/c2cs35130g10.1039/c2cs35130g ↗
46. 10.1002/asia.20180081210.1002/asia.201800812 ↗
47. 10.1016/j.jconrel.2020.02.01910.1016/j.jconrel.2020.02.019 ↗
48. 10.1016/j.drudis.2020.11.00710.1016/j.drudis.2020.11.007 ↗
49. 10.3390/polym1109144110.3390/polym11091441 ↗
50. 10.1002/adtp.20180010310.1002/adtp.201800103 ↗
51. 10.1016/j.progpolymsci.2016.09.00510.1016/j.progpolymsci.2016.09.005 ↗
52. 10.1039/C1CS15242D10.1039/C1CS15242D ↗
53. 10.1021/ja510584810.1021/ja5105848 ↗
54. 10.1016/j.cej.2020.12612510.1016/j.cej.2020.126125 ↗
55. 10.1021/acsami.0c1611010.1021/acsami.0c16110 ↗
56. 10.1039/D0BM00827C10.1039/D0BM00827C ↗
57. 10.1021/acs.biomac.1c0017310.1021/acs.biomac.1c00173 ↗
58. 10.1039/D0CS00011F10.1039/D0CS00011F ↗
59. 10.1039/D0CC07247H10.1039/D0CC07247H ↗
60. 10.1021/acsami.0c0733310.1021/acsami.0c07333 ↗
61. 10.1021/acs.chemrev.9b0083910.1021/acs.chemrev.9b00839 ↗
62. 10.1021/jacs.8b0440010.1021/jacs.8b04400 ↗
63. 10.1002/adma.20200729310.1002/adma.202007293 ↗
64. Liu T. J. · Adv. Funct. Mater. · 2019 · 29
65. 10.1002/anie.20190088610.1002/anie.201900886 ↗
66. 10.1038/s41565-020-00782-310.1038/s41565-020-00782-3 ↗
67. 10.1002/adma.20190589910.1002/adma.201905899 ↗
68. 10.1016/j.biomaterials.2020.11976010.1016/j.biomaterials.2020.119760 ↗
69. 10.7150/thno.4784910.7150/thno.47849 ↗
70. 10.1016/j.biomaterials.2015.10.05610.1016/j.biomaterials.2015.10.056 ↗
71. 10.1021/ja409686x10.1021/ja409686x ↗
72. 10.1016/j.jconrel.2020.06.00510.1016/j.jconrel.2020.06.005 ↗
73. 10.1002/adma.20180392610.1002/adma.201803926 ↗
74. 10.1002/marc.20180038110.1002/marc.201800381 ↗
75. 10.1002/adma.20170014110.1002/adma.201700141 ↗
76. 10.1002/anie.20200418110.1002/anie.202004181 ↗
77. 10.1002/adma.20170622010.1002/adma.201706220 ↗
78. 10.1021/acs.nanolett.0c0502810.1021/acs.nanolett.0c05028 ↗
79. 10.1002/adma.20170598010.1002/adma.201705980 ↗
80. 10.1021/acsnano.7b0861610.1021/acsnano.7b08616 ↗
81. 10.1002/adfm.20160509410.1002/adfm.201605094 ↗
82. 10.1002/anie.20180881110.1002/anie.201808811 ↗
83. 10.1038/nnano.2013.30210.1038/nnano.2013.302 ↗
84. 10.1021/nn305864210.1021/nn3058642 ↗
85. 10.1002/smll.20140209210.1002/smll.201402092 ↗
86. 10.1021/jacs.6b0971310.1021/jacs.6b09713 ↗
87. 10.1002/anie.20100016210.1002/anie.201000162 ↗
88. 10.1002/anie.20150981010.1002/anie.201509810 ↗
89. 10.1002/anie.20060318210.1002/anie.200603182 ↗
90. 10.1021/jacs.0c1285110.1021/jacs.0c12851 ↗
91. 10.1002/anie.20201021610.1002/anie.202010216 ↗
92. 10.1002/adfm.20160509410.1002/adfm.201605094 ↗
93. 10.1016/j.molmed.2010.08.00110.1016/j.molmed.2010.08.001 ↗
94. Ranganathan R. · Int. J. Nanomed. · 2012 · 7 · 1043
95. 10.1038/natrevmats.2017.2010.1038/natrevmats.2017.20 ↗
96. 10.1211/jpp.57.10.000110.1211/jpp.57.10.0001 ↗
97. 10.1002/adtp.20200020610.1002/adtp.202000206 ↗
98. 10.1126/sciadv.abd676410.1126/sciadv.abd6764 ↗
99. 10.1002/anie.20191443410.1002/anie.201914434 ↗
100. 10.1002/adma.20200216010.1002/adma.202002160 ↗